Molecular characterization of interdigitating dendritic cell sarcoma

Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease- free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Glen J, Alarcon, Arlet, Halepota, Maqbool, Penny, Robert J, Von Hoff, Daniel D
Formato: Texto
Lenguaje:English
Publicado: PagePress 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994531/
https://www.ncbi.nlm.nih.gov/pubmed/21139965
http://dx.doi.org/10.4081/rt.2010.e50
Descripción
Sumario:Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease- free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that could be used in the event of disease recurrence.

Ejemplares similares